Myeloglycan, a series of E-selectin-binding polylactosaminolipids found in normal human leukocytes and myelocytic leukemia HL60 cells

Biochemical and Biophysical Research Communications
M R StroudV N Reinhold

Abstract

Sialosyl-Lex (SLex) is assumed to be the binding epitope of E- and P-selectin in normal human neutrophils and myelocytic leukemia HL60 cells. Glycosphingolipid (GSL) fractions from large quantities of normal human neutrophils and HL60 cell extract did not contain SLex GSLs having 6-10 sugar residues, as commonly found in solid tumor cells and tissues. Instead, the binding target of E-selectin was revealed to be a series of long-chain, unbranched polylactosamine GSLs with terminally sialylated, internally alpha 1-->3 polyfucosylated structure as the major component, or having SLex at the terminus and internally polyfucosylated structure as a minor component. These GSLs are hereby collectively termed "myeloglycan." Regardless of the site of fucosylation, all myeloglycans cross-react strongly with "anti-SLex" monoclonal antibodies such as CSLEX, FH6, SNH3, and SNH4.

Citations

Oct 1, 2005·Analytical Chemistry·David AshlineVernon Reinhold
Nov 7, 1998·American Journal of Respiratory Cell and Molecular Biology·M K KimB S Bochner
Oct 28, 2008·Nature Chemical Biology·Samah Zeineb Gadhoum, Robert Sackstein
Oct 1, 1975·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M GosalvezH Reinhold
Mar 16, 2018·Mediators of Inflammation·Sabine GröschElisabetta Albi
May 26, 2004·Archives of Biochemistry and Biophysics·Ronald L Schnaar
May 26, 2004·Archives of Biochemistry and Biophysics·John L Magnani

❮ Previous
Next ❯

Related Concepts

Related Feeds